The U.S. Food and Drug Administration said on Tuesday it is launching a program under which its commissioner can issue ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing a ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...

"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...

Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...

Kraft Heinz plans to remove all artificial dyes from its U.S. products by 2027 amid the Trump administration's push to remove ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...